Intestinal inflammation caused by anti-cancer drugs is ameliorated by ginsenoside

被引：0
|
作者：
Tsujii, Taisei
Kato, Daisuke
Jonan, Shizuka
Amagase, Kikuko
机构：
来源：
PHYSIOLOGY | 2023年 / 38卷
关键词：
D O I：
10.1152/physiol.2023.38.S1.5734772
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Anti-Cancer Drugs: The mitochondrial paradox
    Penman, Sophie L.
    Jensen, Rebecca L.
    Kiy, Robyn T.
    Chadwick, Amy E.
    ELIFE, 2020, 9
  • [32] APPROACHES TO EFFECTIVE ANTI-CANCER DRUGS
    NEIDLE, S
    NATURE, 1977, 268 (5617) : 195 - 196
  • [33] Are isothiocyanates potential anti-cancer drugs?
    Xiang Wu
    Qing-hua Zhou
    Ke Xu
    Acta Pharmacologica Sinica, 2009, 30 : 501 - 512
  • [34] Intrinsically Fluorescent Anti-Cancer Drugs
    Kabir, Md Lutful
    Wang, Feng
    Clayton, Andrew H. A.
    BIOLOGY-BASEL, 2022, 11 (08):
  • [35] ACCESS TO EXPENSIVE ANTI-CANCER DRUGS
    Sullivan, Danny
    Mileshkin, Linda
    JOURNAL OF LAW AND MEDICINE, 2011, 19 (02) : 232 - 243
  • [36] Phosphodiesterase inhibitors as anti-cancer drugs
    Hirsh, L
    Dantes, A
    Suh, BS
    Yoshida, Y
    Hosokawa, K
    Tajima, K
    Kotsuji, F
    Merimsky, O
    Amsterdam, A
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 981 - 988
  • [37] SRC as a target for anti-cancer drugs
    Levitzki, A
    ANTI-CANCER DRUG DESIGN, 1996, 11 (03): : 175 - 182
  • [38] PROBLEMS OF TOXICITY OF ANTI-CANCER DRUGS
    YOUNG, RSK
    FEDERATION PROCEEDINGS, 1979, 38 (01) : 113 - 114
  • [39] Optional copayments on anti-cancer drugs
    van de Vooren, Katelijne
    Curto, Alessandro
    Garattini, Livio
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [40] SORBENT REMOVAL OF ANTI-CANCER DRUGS
    RAHMAN, A
    WINCHESTER, JF
    KESSLER, A
    SLAVIK, M
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 233 - 233
12345